izpis_h1_title_alt

Potential medical use of fullerenols after two decades of oncology research
ID Injac, Rade (Author)

.pdfPDF - Presentation file, Download (888,68 KB)
MD5: 545F7FBB90BDA4C17DEAC7669476FAF9
URLURL - Source URL, Visit https://journals.sagepub.com/doi/10.1177/15330338231201515 This link opens in a new window

Abstract
Fullerenes are carbon molecules that are found in nature in various forms. They are composed of hexagonal and pentagonal rings that create closed structures. Almost 4 decades ago, fullerenes were identified in the form of C$_{60}$ and C$_{70}$, and following the award of the Nobel Prize in Chemistry for this discovery in 1996, many laboratories started working on their water-soluble derivatives that could be used in different industries, including pharmaceutical industries. One of the first fullerene forms that was the focus of different research groups was fullerenol, C$_{60}$(OH)$_n$ (n = 2-44). Both in-vitro and in-vivo studies have shown that polyhydroxylate fullerene derivatives can potentially be used as either antioxidative agents or cytostatics (depending on their co-administration, forms, and concentration/dose) in biological systems. The current review aimed to present a critical view of the potential applications and limitations of fullerenols in oncology, as understood from the past 2 decades of research.

Language:English
Keywords:fullerenol, toxicity, oxidative stress, organ protection, cytostatics, oncology
Work type:Article
Typology:1.02 - Review Article
Organization:FFA - Faculty of Pharmacy
Publication status:Published
Publication version:Version of Record
Year:2023
Number of pages:21 str.
Numbering:Vol. 22
PID:20.500.12556/RUL-154171 This link opens in a new window
UDC:621.3:61
ISSN on article:1533-0346
DOI:10.1177/15330338231201515 This link opens in a new window
COBISS.SI-ID:169696003 This link opens in a new window
Publication date in RUL:29.01.2024
Views:421
Downloads:41
Metadata:XML DC-XML DC-RDF
:
Copy citation
Share:Bookmark and Share

Record is a part of a journal

Title:Technology in cancer research and treatment
Publisher:SAGE
ISSN:1533-0346
COBISS.SI-ID:2235761 This link opens in a new window

Licences

License:CC BY-NC 4.0, Creative Commons Attribution-NonCommercial 4.0 International
Link:http://creativecommons.org/licenses/by-nc/4.0/
Description:A creative commons license that bans commercial use, but the users don’t have to license their derivative works on the same terms.

Similar documents

Similar works from RUL:
Similar works from other Slovenian collections:

Back